267 related articles for article (PubMed ID: 6208127)
1. Protein A binding assay for the identification of HLA antigens on peripheral blood lymphocytes by monoclonal antibodies: application to HLA B27.
Yang YH; Grumet FC; Fendly B; Engleman E; Shively JE
Hybridoma; 1982; 1(3):243-55. PubMed ID: 6208127
[TBL] [Abstract][Full Text] [Related]
2. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
Yannelli JR; Moore LC; Engelhard VH
J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
[TBL] [Abstract][Full Text] [Related]
3. One allogeneic cytolytic T lymphocyte clone distinguishes three different HLA-B27 subtypes: identification of amino acid residues influencing the specificity and avidity of recognition.
Aparicio P; Vega MA; López de Castro JA
J Immunol; 1985 Nov; 135(5):3074-81. PubMed ID: 2413111
[TBL] [Abstract][Full Text] [Related]
4. Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants.
Brodsky FM; Parham P
J Immunol; 1982 Jan; 128(1):129-35. PubMed ID: 6172474
[TBL] [Abstract][Full Text] [Related]
5. Clonal heterogeneity of HLA-B27 cellular allorecognition. Delineation of immunodominant sites.
Aparicio P; Jaraquemada D; Rojo S; López de Castro JA
Eur J Immunol; 1988 Feb; 18(2):203-9. PubMed ID: 2450755
[TBL] [Abstract][Full Text] [Related]
6. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
[TBL] [Abstract][Full Text] [Related]
7. Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies.
Parham P; Antonelli P; Herzenberg LA; Kipps TJ; Fuller A; Ward FE
Hum Immunol; 1986 Jan; 15(1):44-67. PubMed ID: 2419285
[TBL] [Abstract][Full Text] [Related]
8. Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies.
Parham P
J Immunol; 1984 Jun; 132(6):2975-83. PubMed ID: 6202768
[TBL] [Abstract][Full Text] [Related]
9. Anti-HLA-B7,B27,Bw42,Bw54,Bw55,Bw56, Bw67,Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay.
Sakaguchi K; Ono R; Tsujisaki M; Richiardi P; Carbonara A; Park MS; Tonai R; Terasaki PI; Ferrone S
Hum Immunol; 1988 Mar; 21(3):193-207. PubMed ID: 3259570
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric HLA-B27 screening: cross-reactivity patterns of commercially available anti-HLA-B27 monoclonal antibodies with other HLA-B antigens.
Levering WH; Wind H; Sintnicolaas K; Hooijkaas H; Gratama JW
Cytometry B Clin Cytom; 2003 Jul; 54(1):28-38. PubMed ID: 12827665
[TBL] [Abstract][Full Text] [Related]
11. Description of a mouse monoclonal anti-HLA-B27 antibody HLA-ABC-m3.
Trapani JA; Vaughan HA; Sparrow RL; Tait BD; McKenzie IF
Hum Immunol; 1983 Aug; 7(4):205-16. PubMed ID: 6604046
[TBL] [Abstract][Full Text] [Related]
12. Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones.
Aparicio P; Rojo S; Jaraquemada D; López de Castro JA
J Immunol; 1987 Aug; 139(3):837-41. PubMed ID: 2439595
[TBL] [Abstract][Full Text] [Related]
13. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
el-Zaatari FA; Sams KC; Taurog JD
J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
[TBL] [Abstract][Full Text] [Related]
14. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
López D; Barber DF; Villadangos JA; López de Castro JA
J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
[TBL] [Abstract][Full Text] [Related]
16. A cloned cytotoxic T-lymphocyte (CTL) line recognizing a subtype of HLA B27.
Breuning MH; Spits H; de Vries JE; Iványi P
Hum Immunol; 1984 Apr; 9(4):231-42. PubMed ID: 6201469
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of monoclonal antibodies to bovine beta 2-microglobulin.
Guidry AJ; Shapiro RP; Srikumaran S; Nickerson SC; Goldsby RA
Am J Vet Res; 1988 Jun; 49(6):847-50. PubMed ID: 3041882
[TBL] [Abstract][Full Text] [Related]
18. The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificity.
Bernhard EJ; Le AX; Yannelli JR; Holterman MJ; Hogan KT; Parham P; Engelhard VH
J Immunol; 1987 Dec; 139(11):3614-21. PubMed ID: 2445816
[TBL] [Abstract][Full Text] [Related]
19. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
20. Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria.
Kono DH; Ogasawara M; Effros RB; Park MS; Waldord RL; Yu DT
Clin Exp Immunol; 1985 Sep; 61(3):503-8. PubMed ID: 3878239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
